Skip to main content
Springer Nature Link
Log in

Comparison of a cloned ANF-sensitive guanylate cyclase (GC-A) with particulate guanylate cyclase from adrenal cortex

  • Published:
View saved research
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Recently, an ANF-sensitive guanylate cyclase (GC-A) has been cloned from a rat brain cDNA library. Here we studied the stimulation of cyclic GMP accumulation in response to atrial natriuretic factor (ANF), urodilatin and atriopeptin I (AP-1) in a rat glioma C6 cell line permanently transfected with GC-A as well as GC-A activity in membranes from these C6 cells and in membranes from COS-7 cells that were transiently transfected with GC-A. We also measured binding affinities for these natriuretic peptides in the membrane preparations. These characteristics of GC-A were compared to those of membrane preparations from adrenal cortex of bovine and human origin. The order of potency of stimulation of cyclic GMP accumulation in permanently transfected glioma cells was ANF > urodilatin > AP I; AP I stimulated cyclic GMP accumulation. A similar order of potency was obtained for stimulation of guanylate cyclase activity in membranes from permanently transfected glioma cells as well as from transiently transfected COS-7 cells. In contrast, AP-1 was uneffective to stimulate guanylate cyclase in membrane preparations from adrenal cortex from bovine as well as from human origin. Furthermore, urodilatin was equipotent to ANF in these preparations. Binding affinities were comparable for ANF and urodilatin in membranes from cells transfected with GC-A and in membranes from adrenal cortex of both sources, whereas AP-1 had a weaker affinity in all preparations studied.

These results suggest that GC-A is different from ANF-sensitive guanylate cyclase from bovine and human adrenal cortex and that these cyclases can be distinguished by the ability of AP-1 as well as urodilatin to stimulate guanylate cyclase activity. Since binding characteristics for the studied peptides were comparable, the signal transduction mechanisms rather than binding characteristics may be different in ANF-sensitive guanylate cyclase from adrenal cortex and in GC-A.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  • de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89–94

    Google Scholar 

  • Chang M, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddell DV (1989) Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341:68–72

    Google Scholar 

  • Chinkers M, Garbers DL (1989) The protein kinase domain of the ANP receptor is required for signaling. Science 245:1392–1394

    Google Scholar 

  • Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338:78–83

    Google Scholar 

  • Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684–687

    Google Scholar 

  • De Lean A, Gutkowska J, McNicoll N, Schiller PW Cantin M, Genest J (1984) Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci 35:2311–2318

    Google Scholar 

  • Felgner PL, Gadek TR, Holm M, Roman R, Chen HW, Wenz H, Northrop JF, Ringold GM, Danielsen M (1987) Lipofectin: A highly efficient, lipid-mediated DNA-transduction procedure. Proc Natl Acad Sci USA 84:7413–7417

    Google Scholar 

  • Feller SM, Gagelmann M, Forssmann WG (1989) Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci 10:93–94

    Google Scholar 

  • Fülle H-J, Heim J-M, Gerzer R (1991) Functional modulation of ANF-sensitive guanylate cyclase by redox mechanisms. Eur J Pharmacol (Mol Pharmacol Sect) 206:69–75

    Google Scholar 

  • Fuller F, Porter JG, Arfsten A, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB (1988) Atrial natriuretic clearance receptor. J Biol Chem 263:9595–9401

    Google Scholar 

  • Heim J-M, Ivanova K, Gerzer R (1988) Amiloride increases the sensitivity of particulate guanylate cyclase to atrial natriuretic factor. Biochem Biophys Res Commun 152:1263–1268

    Google Scholar 

  • Heim J-M, Kiefersauer S, Fülle H-J, Gerzer R (1989) Urodilatin and \-ANF: Binding properties and activation of particulate guanylate cyclase. Biochem Biophys Res Commun 163:37–41

    Google Scholar 

  • Hintze TH, Currie MG, Needleman P (1985) Atriopeptins: renal-specific vasodilators in conscious dogs. Am J Physiol 248:H587-H591

    Google Scholar 

  • Holleman WH, Bush EN, Devine EM, Firestone SL, Rockway TW, Sarin VK, Budzik GP (1988) Atrial natriuretic factor: structural requirements of the peptide for receptor binding, biological activity, and cGMP stimulation. Drug Developm Res 12:109–117

    Google Scholar 

  • Inagami T (1989) Atrial natriuretic factor. J Biol Chem 264:3043–3046

    Google Scholar 

  • Ivanova K, Heim J-M, Gerzer R (1990) Kinetic characterization of atrial natriuretic factor-sensitive particulate guanylate cyclase. Eur J Pharmacol (Mol Pharmacol Sect) 189:317–326

    Google Scholar 

  • Kentsch M, Ludwig D, Gerzer R, Müller-Esch E (1990) Hämodynamische und diuretische Effekte von Urodilatin (95–126-ANF) bei Probanden. Z Kardiol 79 [Suppl 1]:158

    Google Scholar 

  • Koesling D, Harteneck C, Humbert P, Bosserhof A, Frank R, Schultz G, Böhme E (1990) FEBS Lett 266:128–132

    Google Scholar 

  • Kuno T, Andresen JW, Kamisaki Y, Waldman SA, Chang LY, Saheki S, Leitman DC, Nakane M, Murad F (1986) Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 261:5817–5823

    Google Scholar 

  • Leitman DC, Andresen JW, Kuno T, Kamisaki Y, Chang JK, Murad F (1986) Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem 261:11650–11655

    Google Scholar 

  • Leitman DC, Andresen JW, Catalano RM, Waldman SA, Tuan JJ, Murad F (1988) Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J Biol Chem 263:3720–3728

    Google Scholar 

  • Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, Goeddel DV (1989) Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 8:1377–1384

    Google Scholar 

  • Lowry DH, Roseborough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin Phenol Reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238:675–678

    Google Scholar 

  • Meloche S, McNicoll N, Liu B, Ong H, De Lean A (1988) Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amiloride. Biochemistry 27:8151–8158

    Google Scholar 

  • Mizuno T, Katafuchi T, Hagiwara H, Ito T, Kangawa K, Matsuo H, Hirose S (1990) Human adrenal tumor cell line SW-13 contains a natriuretic peptide receptor system that responds preferentially to ANP among various natriuretic peptides. Biochem Biophys Res Commun 173:886–893

    Google Scholar 

  • Nakane M, Ara K, Saheki S, Kuno T, Buechler W, Murad F (1990) Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265: 16841–16845

    Google Scholar 

  • Needleman P, Blaine EH, Greenwald JE, Michener ML, Saper CB, Stockmann PT, Tolunay HE (1989) The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol 29:23–54

    Google Scholar 

  • Nussenzveig DR, Lewicki JA, Maack T (1990) Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265:20952–20958

    Google Scholar 

  • Paul AK, Marala RB, Jaiswal RK, Sharma RK (1987) Coexistence of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein. Science 235:1224–1226

    Google Scholar 

  • Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:357–363

    Google Scholar 

  • Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG (1990) Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in man. Am J Physiol 259:F832-F838

    Google Scholar 

  • Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL (1989) The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58:1155–1162

    Google Scholar 

  • Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of “Urodilatin” a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752–759

    Google Scholar 

  • Takayanagi R, Snajdar RM, Imada T, Tamura M, Pandey KN, Misono KS, Inagami T (1987) Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: guanylate cyclase-linked and cyclase-free receptors. Biochem Biophys Res Commun 144:244–250

    Google Scholar 

  • Wakitani K, Oshima T, Loewy AD, Holmberg SW, Cole BR, Adams SP, Fok KF, Currie MG, Needleman P (1985) Comparative vascular pharmacology of the atriopeptins. Circ Res 56:621–627

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Labor für klinische Pharmakologie, Medizinische Klinik, Klinikum Innnenstadt der Universität, Ziemssenstrasse 1, W-8000, München 2, Federal Republic of Germany

    Jörg-Martin Heim, Sujay Singh, Hans-Jürgen Fülle & Rupert Gerzer

Authors
  1. Jörg-Martin Heim
    View author publications

    Search author on:PubMed Google Scholar

  2. Sujay Singh
    View author publications

    Search author on:PubMed Google Scholar

  3. Hans-Jürgen Fülle
    View author publications

    Search author on:PubMed Google Scholar

  4. Rupert Gerzer
    View author publications

    Search author on:PubMed Google Scholar

Additional information

Send offprint requests to J. M. Heim at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heim, JM., Singh, S., Fülle, HJ. et al. Comparison of a cloned ANF-sensitive guanylate cyclase (GC-A) with particulate guanylate cyclase from adrenal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 345, 64–70 (1992). https://doi.org/10.1007/BF00175471

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1007/BF00175471

Key words